Paste your Google Webmaster Tools verification code here
When six biotech start-ups in the US decided to go public in January, it surely hinted towards a far more brisk IPO market than the last year. Not one or two but six trend setters in the biotech field had decided to go public this definitely filled in for the shoes for the dull market scenario last year that had came to a near standstill by the second half of the year. Audentes Therapeutics, Editas Medicine, Corvus Pharmaceuticals, Reata Pharmaceuticals, Syndax Pharmaceuticals and Bavarian Nordic are the names that have created a wave of IPOs in the market. While the US has a far more stable biotech scenario, India is still taking nascent steps. And that US has given six reasons to celebrate the biotech stock market; we wonder when would India see such a fate?
Read More: Biotecnika Magazine- February 2016
Shekhar Suman is a Serial Entrepreneur and the Co-Founder of Biotecnika. Magazine is a way he wants to recraft the way industry opines and expresses its views. With years of experience under his belt, he captains the ship with prudence and perfection. He is the chief-editor of Biotecnika Magazine and a big inspiration to the bio-community.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
2014 Powered By Wordpress, Goodnews Theme By Momizat Team